ArticleVaccine2019

Response to: A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.

P Gillard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.